Management Team

Tim Wilson, PhD.

Chief Executive Officer

Tim’s career in the life sciences has encompassed start ups, venture capital, investment banking and equity research. He has held senior positions at a number of firms including


Kevin FitzGerald

Chief Scientific Officer

Kevin began his career in the biotechnology industry at Cambridge Antibody Technology (now part of Medimmune, an AstraZeneca company) when CAT was still in its start-up phase. He


Nick Robbins-Cherry

Chief Financial Officer

Nick brings over 30 years of experience in fundraising, public markets and private equity, gained through financial and commercial roles in international pharmaceuticals and technology businesses. Most recently,


José Iglesias

Chief Medical Officer

José has an over 30 years’ career in the pharmaceutical Industry, both in large pharma and biotech, and has wide experience in designing and leading all Phases (I-IV)


Ashley Nagle

Chief Business Officer

Ashley brings over 25 years of experience leading business and strategy development, licensing and deal-making within the biopharmaceutical industry. Most recently, Ashley served as VP of Business Development


Leanne Partington

VP of Product Development

Leanne has over 20 years’ experience developing therapeutics from bench to clinic. She has worked as a scientist to develop vaccines at the Defence Science and Technology Laboratory


Andrew Calam

VP of Clinical Operations

Andrew has over 25 years of experience in the life sciences industry, holding management and executive positions in both the CRO and biotechnology sector, supporting pharmaceutical development. Andrew


Elizabeth Hardaker

VP of Biology

Elizabeth has more than 15 years’ experience in the pharmaceutical industry. Most recently, Elizabeth was a Senior Director at AstraZeneca leading a team supporting preclinical research in Oncology.